MTSL Celebrates 700 Issues

First Newsletter Devoted to Biotech Remains the Industry Leader

MTSL is celebrating our 700th Issue, but you take home the presents. For a limited time, subscribe to the Letter for only $700 for 3 years - a 27% discount from the annual rate.

Reading the Medical Technology Stock Letter will keep you informed on all aspects of the biotechnology industry, from basic science and research to the latest regulatory trends to disease-specific analysis.  Plus, we keep in mind the thing that drew us to biotechnology in the first place – the promise of better medicines and better treatments for our friends and loved ones when they get sick.  We recommend to you a strong stable of public biotech companies and bring you up-to-the-minute analysis on factors affecting their prospects.  After almost 30 years of covering biotechnology, MTSL has become a trusted source for investors and an invaluable tool for industry insiders looking to stay ahead of regulators and the competition.

To find out more, request a free issue of MTSL then go to our Archives page to see what you've been missing.  Already convinced?  Go here to subscribe.

Our subscription rates:-

1 year @ $320 (24 issues)
2 years @ $575 (48 issues)
Limited Time Offer: 3 years @ $700 (72 issues)
4 years @ $975 (96 issues)
5 years @ $1,150 (120 issues)

(*For hard copy delivery, add $60 per year for printing, postage, and handling.)